BioForce Nanosciences Holdings, Inc.
BFNH
$0.60
$0.2466.67%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 1.99% | -1.66% | -2.15% | -2.80% | -3.93% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 1.99% | -1.66% | -2.15% | -2.80% | -3.93% |
Operating Income | -1.99% | 1.66% | 2.15% | 2.80% | 3.93% |
Income Before Tax | -1.99% | 1.66% | 2.15% | 2.80% | 3.93% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -1.99% | 1.66% | 2.15% | 2.80% | 3.93% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -1.99% | 1.66% | 2.15% | 2.80% | 3.93% |
EBIT | -1.99% | 1.66% | 2.15% | 2.80% | 3.93% |
EBITDA | -- | -- | -- | -- | -- |
EPS Basic | -2.48% | 1.22% | 1.82% | 3.01% | 4.17% |
Normalized Basic EPS | -2.00% | 1.96% | 2.91% | 2.91% | 4.76% |
EPS Diluted | -1.80% | 0.89% | 1.33% | 2.20% | -12.12% |
Normalized Diluted EPS | -2.00% | 1.96% | 2.91% | 2.91% | 4.76% |
Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |